Three-dimensional matrix for producing living tissue equivalents
OwnerCharles W. Hewitt, Louise Strande +1inventors
InventorsCharles W. Hewitt, Louise Strande, Kevin M. Schuster
Life of this patent
Estimating the term…
Loading patent…
OwnerCharles W. Hewitt, Louise Strande +1inventors
InventorsCharles W. Hewitt, Louise Strande, Kevin M. Schuster
Estimating the term…
The primary aspect of the present invention it directed to a three-dimensional matrix, a living tissue equivalent, a tissue microarray, methods of making thereof, and methods of using thereof. In one embodiment of the invention, the three-dimensional matrix comprises fibroblasts and a fibrin matrix. In a preferred embodiment, the three-dimensional matrix comprises blood plasma, thrombin and fibroblasts. The three-dimensional matrix in accordance with this invention may be used to construct living tissue equivalents, including but not limited to skin, blood vessel, bone, tendon, ligaments, and organ equivalents, among many others. Furthermore, the living tissue equivalents may be used to test the effect of various agents and to study the mechanism of disease and the efficacy of various treatment protocols.
A three-dimensional matrix comprising a fibrin matrix and fibroblasts.
A method of producing a three-dimensional matrix comprising mixing fibroblasts, thrombin, and fibrinogens or a blood plasma to form a mixture.
A method of producing a three-dimensional matrix having a desired shape, comprising:
A method of producing a three-dimensional matrix having a desired shape, comprising:
A living tissue equivalent comprising a fibrin matrix, fibroblasts, and cells, wherein the cells are not fibroblasts.
A method of producing a living tissue equivalent comprising mixing thrombin, fibroblasts, cells, fibrinogens or a blood plasma, wherein the cells are not fibroblasts.
A method of producing a living tissue equivalent having a desired shape, comprising:
A method of producing a living tissue equivalent having a desired shape, comprising:
A method of testing the effect of an agent, comprising:
A method of testing the efficacy of a therapy treatment on a diseased tissue, comprising:
A method of screening an agent, comprising:
A method of expressing a desired protein in a tissue, comprising:
A method of producing a skin equivalent, comprising:
A method of producing a blood vessel equivalent, comprising:
A method of producing a bone tissue equivalent, comprising:
A method of producing a bone equivalent, comprising:
A method of producing a cartilage tissue equivalent, comprising:
A tissue microarray comprising a multiplicity of tissue equivalent blocks, wherein the tissue equivalent blocks are formed through slicing a living tissue equivalent comprising a mixture of a blood plasma or fibrinogens, thrombin, fibroblasts, and cells, wherein the cells are not fibroblasts.
A method of producing a tissue microarray, comprising:
A method of replacing a tissue in a body, comprising:
Dependencies are inferred from the claim text.